combination therapies

Research in Review
Better Biomarker-Driven Treatment Strategies Needed for NSCLC
08/11/2016
JCP Editors
A trial assessing the clinical effectiveness of biomarker-based treatments provided additional support for the use of targeted therapeutic options, but also called attention to the need for better biomarker-driven...
A trial assessing the clinical effectiveness of biomarker-based treatments provided additional support for the use of targeted therapeutic options, but also called attention to the need for better biomarker-driven...
A...
08/11/2016
Journal of Clinical Pathways
Research in Review
Bortezomib Regimen More Cost Effective Than Current Standard for Mantle Cell Lymphoma
08/05/2016
JCP Editors
Bortezomib plus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (VR-CAP) may be a more cost-effective treatment option in the United Kingdom for patients with previously untreated mantle cell...
Bortezomib plus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (VR-CAP) may be a more cost-effective treatment option in the United Kingdom for patients with previously untreated mantle cell...
...
08/05/2016
Journal of Clinical Pathways
Research in Review
Immunotherapy Plus Chemotherapy Does not Improve SCLC Outcomes
08/05/2016
JCP Editors
The addition of ipilimumab to etoposide and a platinum agent failed to demonstrate improved survival in patients with extensive-stage small-cell lung cancer when compared with chemotherapy alone, a study published in...
The addition of ipilimumab to etoposide and a platinum agent failed to demonstrate improved survival in patients with extensive-stage small-cell lung cancer when compared with chemotherapy alone, a study published in...
The...
08/05/2016
Journal of Clinical Pathways
Research in Review
Ipilimumab Combination Significantly Improves Melanoma Outcomes
07/27/2016
JCP Editors
Ipilimumab (Yervoy; Bristol-Myers Squibb) combined with local peripheral treatments such as radiotherapy or electrochemotherapy may significantly prolong survival in patients with melanoma compared with...
Ipilimumab (Yervoy; Bristol-Myers Squibb) combined with local peripheral treatments such as radiotherapy or electrochemotherapy may significantly prolong survival in patients with melanoma compared with...
...
07/27/2016
Journal of Clinical Pathways
Research in Review
Statin Use May Improve Survival in Patients With Lung Cancer
07/11/2016
JCP Editors
Statin use may be associated with improved survival among patients with stage IV non-small cell lung cancer (NSCLC), according to findings from a study published in the journal Lung. Prior studies have shown that...
Statin use may be associated with improved survival among patients with stage IV non-small cell lung cancer (NSCLC), according to findings from a study published in the journal Lung. Prior studies have shown that...
Statin...
07/11/2016
Journal of Clinical Pathways
Research in Review
Carfilzomib Cost Effective for Myeloma Treatment
06/01/2016
JCP Editors
Carfilzomib, in combination with lenalidomide and dexamethasone (KRd), may be a cost-effective treatment option for patients with relapsed or refractory multiple myeloma, according to the Kyprolis Global Economic...
Carfilzomib, in combination with lenalidomide and dexamethasone (KRd), may be a cost-effective treatment option for patients with relapsed or refractory multiple myeloma, according to the Kyprolis Global Economic...
...
06/01/2016
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use